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Abstract 
While simulation methods have proved to be very effective in identifying efficiency gains, low 
stakeholder engagement creates a significant limitation on the achievement of simulation modelling 
projects in practice. This study reports causal factors – at two hierarchical levels, i.e. primary and 
secondary - that could significantly affect low stakeholder engagement in healthcare simulation 
projects. A self-completed questionnaire was administered online to 91 experts in the field from 
whom 37 responded. The results were reinforced using a bootstrapped sample (n=1000). Data were 
analysed using descriptive statistics, Kendal’s Tau-b correlations, and non-linear multiple regression. 
Based on our research, while such factors as ‘communication gap’, ‘stakeholders high work-load’ and 
‘too much complexity involved’ represent the most significant primary causal factors, some others 
such as ‘reluctance to change’ proved interestingly insignificant. The research suggests that high-
impact public health projects can exemplify the areas that will potentially generate engagement in 
the healthcare simulation domain. 
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1. INTRODUCTION 
In many countries, there appears to be substantial scope to improve the health status of the 
population without increasing spending, but instead through efficiency gains.1 The empirical results 
of an OECD (Organisation for Economic Co-operation and Development) study suggest that potential 
efficiency gains might be large enough to raise life expectancy at birth by almost three years on 
average for OECD countries, while a 10% increase in total health spending would increase life 
expectancy by only three to four months.1  
Simulation methods have proved to be very effective in identifying efficiency gains. Computer 
simulation has been arguably the second most widely used research method in the field of 
operations management.2 Simulation methods have historically played a major role in system 
improvement initiatives in non-healthcare settings.  The situation in healthcare, however, is mixed. 
While there has been much activity there particularly on system utilisation, policy decision support 
and public health3 , limited evidence of implementation exists.3-6 An example to demonstrate the 
potential, however, is presented in Roberts et al.7  where it is reported that by simulating changes to 
the current care pathway of end-stage renal disease, shifts from medical centre dialysis to either 
home dialysis or cadaver donor transplantation would save $284m per year. The literature 
demonstrates the application of different simulation methods - mostly Monte Carlo Simulation, 
Discrete Event Simulation, System Dynamics and Agent-Based Simulation - in healthcare.8  
A project success is about bringing into play the interests of those who established the project and 
realising their expectation of project achievement.9 Failure to meet stakeholders’ expectations in the 
simulation projects has been a common phenomenon, mainly as a result of lack of shared views 
between simulation providers and customers about the concept of success in the simulation 
projects.10 The literature provides strong evidence that ‘user/stakeholder engagement and support’ 
is the critical factor in the successful ending of various change projects in general11-20, and simulation 
projects in particular21,22. 
Recent studies in the context of healthcare suggest that ‘low stakeholder engagement’ has created a 
significant limitation on the achievement of simulation modelling projects.22,23 Yet, our search – as 
explained in the next section – failed to identify any studies dedicated to the investigation of 
possible causal factors for this. The present article therefore aims to empirically ascertain the most 
important causes of low stakeholder engagement in healthcare simulation projects through a survey 
of expert opinions. Such an investigation will result in a better understanding of the issue and then a 
more informed approach to tackle it.  
  
We begin in section 2 with a summary of research background and its underlying theoretical 
framework. In Section 3, we outline our methods that are used to conduct the research. Section 4 
presents the survey results and analysis. Section 5 presents a discussion of findings and suggestions 
on the implications for research and practice. Section 6 brings the paper to a close and suggests 
future work that might be carried out. 
2. BACKGROUND AND THEORETICAL FRAMEWORK 
What we mean by ‘stakeholders’ in this context, as inspired by Freeman’s definition24, is “individuals, 
groups or organisations that directly or indirectly can affect or be affected by (positively or 
negatively) the simulation modelling project”. More information on the definitions, with a particular 
focus on the healthcare contexts can be seen in Brailsford et al.22  
Research evidence on the stakeholder engagement within the healthcare simulation domain is very 
limited, and mainly in the form of scattered information throughout the literature on the challenges 
of simulation modelling in general5,18,21,25-27 or in some specific contexts such as  healthcare22,23,28-33. 
However, there is a clear gap on the ‘causal study’ of ‘low stakeholder engagement’. The present 
study attempts to fill this gap in the body of knowledge, which would take the research one step 
further towards solving the issue. 
From the published literature34 and using the authors’ experience in the subject matter, we 
identified 18 primary and 44 secondary factors that are expected to have an effect on stakeholder 
engagement in healthcare simulation projects. These factors establish our research hypotheses that 
need to be tested in the research. Table 1 presents these factors along with the literature sources. 
We primarily grouped these factors into four categories i.e. organisational, technical, project 
management and healthcare specific factors based on agreement between two co-authors each 
having more than ten years of experience in simulation modelling. Organisational category 
principally represents the indigenous factors inherent in the host organisation that is the recipient of 
simulation work. The technical factors represent the issues specifically concerned with the 
simulation tools and techniques. The project management category is mainly associated with 
exogenous factors originating from the simulation provider institution and its project management 
style. The healthcare-specific category, however, is different in a way that it has a focus on the 
factors that are mostly associated with the healthcare settings.  
In order to draw implications for research and practice, there is a need for a robust evaluation of our 
categorisation and hierarchical ordering of the causal factors (18 primary and 44 secondary) as 
  
shown in Table 1. In this regard and considering that domain experts are a reliable source of 
informing decision making models / frameworks concerning the issues for which prior data are 
scarce,35 we investigate opinions of experts who are familiar with and experienced in terms of both 
the method, i.e. simulation, and the context, i.e. healthcare systems. 
Table 1 here 
The primary objective of this study is to elicit domain experts’ opinions, which works as a means to 
test the research hypotheses about the causal factors at two hierarchical levels, i.e. primary and 
secondary. The secondary objective is to investigate the associations between various causal factors 
and to determine the contribution, explained as the effect size, of secondary causal factors (SC) in 
explaining the variance in the primary causal factors (PC). 
3. METHODS 
3.1 Cause and effect analysis 
The concepts of ‘cause and effect’, ‘causal factors’ and ‘root cause approach’ used in this study are 
inspired by the work of Ishikawa.36 Anything that affects an effect, either directly or indirectly, is 
defined as a causal factor of that effect. The ‘root cause approach’ tends to identify causal factors in 
a hierarchical order that moves us towards the root causes of an issue. Figure 1 exemplifies the 
approach adopted in this research in two hierarchical levels. 
Figure 1 here. 
3.2 Expert opinion survey 
3.2.1 Participants  
The target population aimed at domain experts having both ‘knowledge’ of and ‘experience of 
involvement’ in healthcare simulation projects. As one important aspect of this research concerned 
about learning from past experiences in real cases especially from the users’ point of view, we 
welcomed opinions from healthcare professionals who have been involved in healthcare simulation 
projects, but with basic knowledge of simulation modelling and its applications. In order to ensure 
that these criteria are met, several steps were followed. First, three types of organisations as the 
sources of potential experts were identified; i.e. healthcare provider organisations, simulation 
software/consulting companies, and academic institutes. Then, three search methods were selected 
that helped us to nominate 91 potential experts. These methods were: (a) search of literature for 
  
people involved in healthcare simulation projects, (b) the member directory of a network of 
simulation modellers and practitioners in healthcare called MASHnet (www.mashnet.info), and (c) 
the authors’ previous contacts through a number of related projects. These 91 people came from a 
variety of professions but all were assumed to meet the ‘knowledge’ and ‘experience’ criteria. And 
finally, two questions were designed in the questionnaire to evaluate the respondents’ simulation 
knowledge and experience in the healthcare contexts, as a result of which, one response was 
removed as been representing one with no experience. The respondents were informed about the 
survey topic, namely ‘healthcare simulation’, and the survey objectives in the ‘Introduction’ part of 
the questionnaire.  
3.2.2 Questionnaire development 
Using an online survey development software and data collection tool called SurveyMonkey®, we 
developed a questionnaire that consisted of three sections as follows.  
a) Introduction: Included information about the survey, the study objectives, a quick guide about 
how to complete the questionnaire, information on ethical issues / approval, and introduction of the 
research team and their contact details.   
b)  About you: This section comprised eight questions that asked information about the 
respondent’s characteristics, including the type of organisation and country they were currently 
working in, level of knowledge about simulation, level of experience in healthcare simulation, and 
contact details (as optional).  
c)  Main topic of the survey: This section was the main part of the survey where experts were asked 
for their opinions about causal factors at two hierarchical levels i.e. 18 primary and 44s secondary 
factors, as presented earlier in Table 1. A balanced five-point Likert scale format (‘strongly agree’, 
‘agree’, ‘neutral’, ‘disagree’, ‘strongly disagree’) plus a ‘don’t know’ option was used to capture 
respondents’ opinions. An example of questions can be seen in Figure 2. In addition, open-ended 
questions and spaces were provided to allow respondents to express their opinions on a more freely 
basis. A copy of the questionnaire is available on request from the authors. 
Figure 2 here. 
3.2.3 Piloting 
The questionnaire was pilot tested and checked for clarity and consistency by six experts in 
healthcare qualitative studies. Suggestions about better articulation of factors and also about 
allowing respondents to express their opinions in an open-ended format were received and 
incorporated in the questionnaire.  
  
3.2.4 Launch and implementation of the survey 
The survey was launched in November 2011 for a period of two weeks. The experts were invited to 
the survey by an email.  Ethics approval for this study was obtained from the relevant ethics 
committee. We did not seek the written consent from the experts for participating in the study; 
however, the return of completed questionnaire was considered as a valid consent of the individual 
participant.   
3.3 Data analysis methods 
Data were processed using the software IBM® PAWS Statistics 18. Participants’ responses were 
coded as ‘strongly agree’ = 1, ‘agree’ = 2, ‘neutral’ =3, ‘disagree’ =4, ‘strongly disagree’ = 5, and 
‘don’t know’ = 0. The Cronbach’s Alpha was used for checking the reliability and internal consistency 
of each causal factor comprising a primary cause (PC) and its secondary causes (SCs). Descriptive 
statistics (i.e. Mean (M), Median (Med), Mode (Mod), and Standard Deviation (SD)) were determined 
on the original sample, which was relatively small (n=37). Bootstrapping approach is useful for 
mitigating the effects of small sample size and lack of normal distribution of data, and making 
reliable statistical inferences.37,38 We therefore used the bootstrapping method as reported. We 
compared the descriptive statistics obtained with the original sample (n=37) with the descriptive 
statistics obtained with a hypothetical larger sample equal to 1000 using bootstrap resampling with 
1000 iterations.39 We used the median values for drawing the inferences because this is a better 
indicator compared to the mean value especially when the data distribution is not normal.40 In fact, 
our data, which was tested by Kolmogorov-Smirnov test and Shapiro-Wilk tests, revealed deviation 
from normal distribution. We therefore used non-parametric Kendall’s Tau correlations, which are 
more suitable for small sample size and not-normally distributed data,40,41 for assessing the 
relationship between primary causal factors (PCs), between secondary causal factors (SCs), and 
between SCs and PCs, using both the original and a bootstrapped sample with 1000 iterations, as 
reported by others.39  
Another possibility of checking relationships between the causal factors could be determined by 
running factor analysis but we could not run this kind of test due to limitations of our data i.e. small 
sample size and non-normal distribution. We did not transform the data to meet the normalised 
data distribution assumption necessary for the multiple linear regression models.41  We therefore  
run non-linear multiple regression models to determine the effect size of each SC in explaining the 
variance in its hypothesised PC and possibly with other PCs to which it was statistically significantly 
correlated (p < 0.05). In non-linear multiple regression modelling, a PC was used as the outcome / 
  
dependent variable while all SCs hypothesised with it were used as independent / predictor 
variables, which were entered simultaneously in the regression model to obtain the non-linear 
regression estimates. Then, the effect size analysis obtained on the original sample was checked by 
non-linear regression estimates obtained on a bootstrapped sample of 1000 experts. 
Finally we used a 2-by-2 matrix as inspired by the widely known Product Portfolio Model42 as a way 
to map the spectrum of simulation modelling applications in healthcare alongside the findings of this 
research, and to offer insights and to instigate further discussions on this topic.   
4. RESULTS AND ANALYSIS 
Forty one out of the 91 experts responded to our survey, making an overall response rate of 45%. 
However, four of the experts completed only section ‘About you’ of the questionnaire, one of whom 
expressed no experience in having been involved in a healthcare simulation project. Therefore, only 
37 forms were considered for the data analysis, making an effective response rate of about 41%.  
Questions about specific causal factors in section C were answered by 78% or more of the 
respondents and the average response rate to these questions was 90%. The results of the 
questionnaire survey are presented in Table 2. 
4.1 Descriptive statistics   
The descriptive statistics for both the original sample and the bootstrapped sample are presented in 
Table 2.  We decided either to ‘retain’ or to ‘exclude’ any of the PCs and SCs based on the following 
protocol: 
 Retain a causal factor: The PCs and SCs with a Median rank from 1 (Strongly agree) to 2 
(Agree) should be retained for further analyses. 
 Exclude a causal factor: All PCs and SCs with a Median rank from 3 (Neutral) to 5 (Strongly 
disagree) should be excluded from further analyses. 
Accordingly, 6 PCs and 18 SCs had the mean and median rankings ≥3, which suggested that the 
experts were either neutral (rank =3) or disagreed (disagree = 4 and strongly disagree = 5) about 
these PCs and SCs being causal factors of low stakeholder engagement in healthcare simulation 
projects. On the other hand, 12 PCs and 26 SCs received the mean and median rankings <3 (i.e. 
strongly agree = 1 and agree = 2), which suggested that among the tested factors (Table 1) the 
experts believed that these were the only reliable causal factors of low stakeholder engagement in 
healthcare simulation projects.  The factors that were found reliable hence retained, and those that 
  
were found unreliable hence excluded are marked as R and E respectively in Column ‘Decision’ in 
Table 2.  
Table 2 here. 
In the following sections, we present our findings related to only the reliable/retained (R) PCs and 
SCs. 
4.2. Correlation analysis  
4.2.1 Correlations between retained PCs 
The non-parametric Kendall’s Tau-b (two-tailed) correlation analysis revealed five significant 
correlations (p < 0.05) between eight out of 12 retained PCs (Table 3) while the remaining PCs were 
not significantly correlated with any other PC.  
Table 3 here. 
4.2.2 Correlations between retained SCs 
Results of non-parametric correlations i.e. Kendall’s Tau-b (two-tailed) between retained SCs (n=26) 
revealed statistically significant associations between the majority of SCs belonging to the same 
group (Table 4).  
Table 4 here. 
SCs that were not statistically significantly associated with other SCs within the same group were 
SC5.3, SC5.4, SC6.1, SC6.2, SC8.1, SC8.2, SC9.3 and SC13.1. There were, however, numerous 
statistically significant associations between SCs belonging to different groups (not reported here 
but available on request from the authors). 
4.2.3 Correlations between retained SCs and retained PCs 
Statistically significant associations between retained SCs and retained PCs are presented in Table 5. 
Results showed that except for SC5.3, SC5.4, SC8.1, SC9.3, SC11.3, SC12.4, SC15.1, SC15.2 and 
SC16.3, all other SCs were statistically significantly associated with the PC within the hypothesised 
group. In addition, there were statistically significant associations between SCs and PCs belonging to 
different groups (Table 5). It is noteworthy that SC5.4, SC9.3, SC11.3 and SC12.4 were not 
statistically significantly associated with any PC. 
  
Table 5 here. 
4.3 Extraction of the variance by SCs in PCs 
4.3.1 Non-linear multiple regression using original and bootstrapped samples  
Results of non-linear multiple regression for determining explanation of the variance by SCs in PCs 
are presented in Table 6. The results from the original sample showed that 17 retained SCs explained 
a significant percentage of the variance in the PC of hypothesised group and the scale reliabilities of 
retained SCs and PC belonging to the same group were α ≥.600. Five SCs – (i.e. 5.3, 5.4, 8.1, 11.3 and 
12.4) - did not explain any significant variance in the PCs of hypothesised groups. In addition, several 
SCs explained statistically significant variance in PCs of other groups; however, the scale reliabilities 
of such alternative associations were low (α <.600) in most of the cases (Table 6). Results of 
bootstrapped non-linear regression comprising only the R2 statistics are also presented in Table 6, 
which confirm that most of the SCs statistically significantly explained the variance in the PC of own 
group and the PCs of other groups. Nevertheless, the magnitude of the variance explained by SCs in 
PCs outside the hypothesised groups was mostly lower compared to the amount of variance 
explained in the PC of hypothesised group.   
4.4 Reliability analysis of retained PCs and associated SCs 
The reliability analysis of each retained PC with its associated SCs (presented in Table 6) revealed 
that all these retained factors have a good Cronbach’s alpha (α ≥ .700) except for PCs 8, 9 and 14 
with their related SCs that have a slightly lower but a respectable reliability (α ≥ .600) (For the 
interpretation of α levels see.43-45 
Table 6 here. 
5.  DISCUSSION AND IMPLICATIONS  
Despite the fact that this survey addressed a specific area and that the questionnaire was long, 
average response rate to the questions about causal factors was high (about 90%). This implies that 
our survey was well received by the respondents. 
5.1 Primary causal factors 
Our results showed that 12 PCs out of 18 PCs were reliable, which we named as retained PCs (Table 
2). Table 7 presents top three statistically significant PCs based on experts’ ratings with 
  
bootstrapped mean and median values of ≤2. Among these PCs, the ‘Communication gap between 
simulation and stakeholder groups (PC5)’ emerged as the strongest causal factor on the basis of the 
mean ranking (i.e. 1.73±0.56) (Table 2). Additionally, all its SCs received a significant support from 
the experts. This finding provides further evidence in support of a number of previous studies, which 
reported that communication between analysts and users is often problematic due to issues such as 
cognitive limitations and vocabulary differences.16,46-48 While the communication gap is arguably a 
universal issue in all sectors, healthcare seems to suffer more from this due to wider background 
differences between the management and the clinical communities. As reflected in the SCs 
associated with the PC5, some part of the communication gap problem also pertains to the 
technology-intensive nature of simulation. This can be supported by the results of correlation 
analysis shown in Table 3 as to suggest that there exists a possible link with technical factors 
represented by PC11. This finding highlights the importance of continuing efforts that have been 
going on to make simulation tools and techniques simple and understandable by the users. 
Table 7 here. 
Our findings also show that ‘Stakeholders high workload (PC2)’ and ‘too much complexity in the 
healthcare settings (PC17)’ are two other significant primary factors that could deter stakeholder 
engagement in simulation projects.    
On the other hand, analysis of the results revealed that experts were either neutral or disagreed 
about six PCs as being the primary causes (denoted as excluded in Table 2). Further investigation 
may be required for some of these excluded PCs. For example ‘reluctance to change (PC1)’, which 
seems to be a common feature of many change projects including simulation ones, could not receive 
enough support as being a causal factor from the experts in our study. Whether this is an 
observation associated with the healthcare contexts remains to be explored. As one of the 
respondents puts it “Stakeholders, especially clinicians, have an urgent desire and enthusiasm for 
change, but have become cynical and disenchanted about the way in which change is conceived, 
implemented and evaluated”.  
The other factor is ‘ethical issues’ about which there were mixed opinions, though the experts 
overall found it less of a real barrier. As two respondents stated, it is more of a ‘red herring’ in 
reality.  
Exclusion of PC15, i.e. ‘failure to meet objectives’ might reflect poor articulation in the questionnaire, 
because both of its hypothesised SCs received a very significant expert support. Therefore, we 
  
suggest that a new PC called as ‘Inadequate definition and affirmation of objectives’, which would 
represent both SC15.1 and SC15.2, replaces PC15.    
5.2 Secondary causal factors 
Table 8 presents top five statistically significant SCs supported by the experts’ ratings. This is based 
on bootstrapped mean and median values of ≤2, as outlined earlier in Table 2. As secondary causal 
factors are meant to be closer to the roots of the issue, careful attention needs to be given to these 
factors, especially to the ones with the most statistically significant ratings as listed in the Table 8. 
Table 8 here. 
An important observation is the retention of some SCs associated with an excluded hypothesised PC. 
In one example as suggested earlier in the previous section, two SCs, i.e. ‘ill-defined objectives 
(SC15.1)’, and ‘lack of focus on objectives (SC15.2)’ merged to create a new PC that replaced PC15. 
Similarly, in the case of SC12.4 (Poor model flexibility), it was converted to a new PC that replaced 
PC12. However, in the case of SC16.3, i.e. ‘Not enough communication between two sides’, it was 
merged with the very closely related SC5.3 (Irregular contacts between two groups) to create a new 
SC called as ‘Irregular or insufficient contacts between two groups’.   
5.2.1 Extraction of the variance in PCs by SCs 
According to Field41 the correlation coefficient can be used to determine the effect size in which the 
coefficient values of ±0.1 (i.e. 10%), ±0.3 (i.e. 30%) and ±0.5 (i.e. 50%) represent a small, medium 
and large effect size respectively. Looking at the findings of extraction of the variance in PCs by SCs 
(Table 6), we believe that retained SCs (Table 2) can be classified into four categories on the basis of 
level of the variance explained in any retained PC (Table 6), as described below.  
5.2.1.1 Strong SCs 
All those SCs that statistically significantly explain 30% or more variance in a hypothesised and/or an 
alternate PC. Consequently, this group of SCs includes SC3.1, SC3.2, SC4.1, SC5.1, SC5.2, SC6.1, SC9.3, 
SC11.1, SC11.2, SC13.1, SC17.1, SC17.2 and SC17.3. 
5.2.1.2 Moderate SCs 
All those SCs that statistically significantly explain 10% - 30% of the variance in a hypothesised 
and/or an alternate PC. This group comprises SC6.2, SC8.2, SC10.1 and SC14.1. 
  
5.2.1.3 Weak SCs 
All SCs that statistically significantly explain less than 10% of the variance in a hypothesised and/or 
an alternate PC. This group includes only SC4.2.  
5.2.1.4 Independent SCs 
All SCs that received experts’ agreement as being a possible SC but they could not explain any 
statistically significant variance in any PCs. This group comprises SC5.4, SC11.3, SC12.4, SC15.1, 
SC15.2 and SC16.3. Amongst these, SC5.4, SC11.3 and SC12.4 were converted to three new 
independent PCs. On the other hand, SC15.1 and SC15.2 were merged together creating a new PC 
because these two SCs were strongly correlated with each other. Finally, SC16.3 was merged with 
SC5.3 to create a new SC, as explained earlier. 
Figure 3 shows a cause and effect diagram that represents the causal relationships in two levels with 
inputs from the analysis of our results as explained above. Additionally, six extra links shown as ‘line 
curves’ were added between a number of SCs and alternative PCs. This is a result of the analysis 
carried out in bottom section of the Table 6 with regards to the associations with reliabilities α 
≥.600.  
Figure 3 here. 
5.3 Implications for healthcare simulation projects  
As secondary causal factors are meant to be closer to the roots of the issue, careful attention needs 
to be given to these factors, and specifically to the most significant ones (Table 8). With regards to 
two secondary factors in Table 8, namely ‘Much variations involved’ and ‘Dynamic and multi-
dimensional nature of healthcare’, we believe that although there is a high level of variations, 
dynamism and complexity inherent in the healthcare systems,30 the healthcare sector represents a 
wide spectrum of complexity levels in the same way as other sectors do. On one side of the 
spectrum, there are areas that are characterised by fewer complexities in a sense that they may 
require less of system details or modelling of interactions and more of aggregate data, which are 
mostly available in public domains. Areas such as prevalence studies of one specific disease from the 
public health perspective belong to this side. These areas are normally covered by system dynamics 
(SD) method. The other side of the spectrum, however, can represent areas that are concerned with 
individuals (patients, clinicians, staff, and others) and modelling their behaviours and interactions 
within a larger system such as a hospital, a local community, or a country. An implication of our 
  
findings could be that if the less complex side of the spectrum, such as the public health 
applications, receives a higher priority and/or publicity, an increasing level of stakeholder 
involvement and subsequent success in healthcare would be realised. Such a general approach tends 
to handle high variations (SC17.1 or causal factor one in Table 8) and dynamism (SC17.3 or causal 
factor four in Table 8), through controlling the scale of datasets and details of the project. This is 
analogous to the discussion of ‘risk management’ in a project where risks are reduced as a result of 
streamlining the project. Furthermore, an increased rate of success that follows the streamlining 
efforts will bring in a domino effect to the future projects, hence addressing the ‘historical failure’ 
factor (SC10.1 or causal factor five in Table 8). 
Another implication, which relates to the factor three in Table 8 (low exposure to simulation or 
SC3.1) would be to give higher priority to addressing more widespread problems with high impacts 
such as public health scenarios or operational management of general hospitals and emergency 
departments, though looking from a wider and system’s perspective. This will result in a wider 
exposure of healthcare systems and stakeholder community (especially clinicians), either directly or 
indirectly, to the benefits and impacts of simulation modelling projects.  
These implications reaffirm the current thoughts in the simulation community by providing more 
logical backing of the idea. We believe that the findings of the current study recognise the vital 
susceptibility of healthcare simulation modelling on two dimensions, namely ‘complexity’ and 
‘impact’. Therefore, we provide further insights into these two dimensions by presenting a 2-by-2 
matrix model view, as inspired by the widely known Product Portfolio Model,42 with ‘problem 
complexity’ and ‘impact or stakeholder coverage’ on each dimension of the matrix (Figure 4). 
Examples in the matrix represent types of application areas that could relate to these two 
dimensions. Top-left and bottom-right boxes in the matrix represent the areas with highest and 
lowest engagement generation in the long-term, respectively. We believe that high-impact public 
health studies can exemplify the areas that will potentially generate engagement in the healthcare 
simulation domain.   
Figure 4 here. 
We also suggest that a structured ‘stakeholder involvement plan’ be developed and exercised 
throughout the project, which would address the factor two (irregular contacts between stakeholder 
and simulation communities or SC5.3) and to some extent the factor three (low exposure to 
simulation or SC3.1) in Table 8. The plan could incorporate key stakeholder groups and will involve 
various engagement models in the form of committees, workshops, or surveys that will take place 
  
on a regular basis. A stakeholder ‘champion’ from within the healthcare organisation could be 
selected to have a key role on the engagement activities. All these and other engagement-related 
arrangements could constitute the plan, which would be developed before a project starts.  
6. CONCLUSIONS 
While there is an evidence claiming that ‘low stakeholder engagement’ has created a significant 
limitation on the achievement of simulation modelling practices in healthcare, an investigation of 
causal factors of ‘low stakeholder engagement’ remains undeveloped.  
Our expert opinion survey highlighted the significance of a number of these causal factors. Overall, 
‘group communications’, ‘system complexity’ and ‘impact’ were found the main areas where 
stakeholder engagement in healthcare simulation generally relate to. The implications of our 
findings highlight priorities that need to be given to the simulation applications with low complexity 
and high impact/stakeholder coverage, such as high impact public health studies and prevalence 
studies of a common disease. 
Another significant finding of our study includes the identification of the factors that received 
experts’ disagreement, such as ‘reluctance to change’. This finding is useful in a way that it will serve, 
through further investigation, to contribute to cross-sectoral comparisons with an aim to evaluate 
contextual effects on the ‘resistance’ factor. Ultimately, it could lead to rectifying some previous 
perceptions or adjusting existing widespread evidence49-52 on the ‘resistance’ factor. 
The identification of causal factors can help simulation practitioners and project managers to avoid 
barriers in involving stakeholders; hence may increase the chance of project’s success. As 
‘stakeholder engagement’  plays a rather universal role in many types of change projects, our survey 
methodology and instruments could make important contributions in providing research community 
in the simulation field with a useful evidence as well as a means to conduct similar studies in other 
fields. Indeed, stakeholder engagement is key to the success of so many other types of projects that 
there is a possibility of major impacts throughout many sectors, if generalisations can be made. 
6.1 Study limitations and future research 
The overall survey response rate was 41%, which seems moderate in the category of expert opinion 
surveys where the respondents (experts) are normally very busy, especially within the healthcare 
industry. Also, the survey sample size was relatively small, which was mainly due to a limited number 
of experts in this field. The sample size issue was, however, overcome to some extent by applying 
  
the bootstrapping methodology for generating a theoretical sample size of 1000 participants (using 
1000 iterations), which is an accepted and reliable statistical technique that is widely used in 
research studies. 
There is a need for further research involving another round of survey on the basis of the findings of 
this study as well as further statistical tests such as the exploratory and confirmatory factor analyses 
and structural equation modelling for knowing the dimensions and the effect of each primary and 
secondary causal factor. Also, further research could be conducted to bring in contextual 
parameters, such as public or private systems, primary or secondary care settings, etc. A larger 
sample of experts could be selected in the further studies. 
We did three sets of correlation analyses, namely a) between PCs, b) between SCs and PCs, and c) 
between SCs under each PC. A further study could also look at the correlations between SCs of 
different groups to explore whether there would be any new information with regards to the causal 
inter-relationships. 
Although this study has focused on simulation, the authors believe that similar research into other 
types of projects might produce comparable conclusions.  
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CAUSAL FACTOR  
Figure 1: An example of the ‘Root Cause’ approach 
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Figure 3: Cause and effect diagram representing factors that cause ‘low stakeholder 
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Figure 4: An ‘impact-complexity matrix model’ representing areas of healthcare applications that can 
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Table 1.  Hypothetical primary and secondary casual factors affecting stakeholder engagement 
in healthcare simulation projects  












PC1 Reluctance to change [28] 
SC1.1 
Strict organisational rules and codes of practice do not 
support change and innovations 
SC1.2 Fear of instability 
PC2 
Stakeholder’s (e.g. clinician’s) 
high workload 
[22, 32] 
SC2.1 Shortage of workforce 
SC2.2 Lack of proper workforce planning 
PC3 
Poor familiarity or awareness of 
simulation 
[26] 
SC3.1 Low exposure to simulation projects 
SC3.2 Lack of background knowledge about simulation 
PC4 
Conflicting views and objectives 
amongst healthcare community 




SC4.1 Difficulty in aligning views and objectives 
SC4.2 Poor communication amongst stakeholders 
PC5 
Communication gap between 




SC5.1 Technical language barrier 
SC5.2 Poor interactive tools or modes of communication  
SC5.3 Irregular contacts between two groups  
SC5.4 Poor awareness of other group’s roles  
PC6 
Stakeholders feeling that the 
project is not producing 
tangible and quick impact 
 [22, 29, 
10, 26, 
33]  
SC6.1 Poor awareness of the potential benefits of the project 
SC6.2 Failure to produce tangible interim results 
PC7 
Lack of explicit request from 
simulation group for active 
participation of stakeholders 
[21] 
SC7.1 Stakeholders’ high expectations 
SC7.2 Possible conflicts amongst various stakeholder groups 
SC7.3 No consultancy fees charged  
PC8 Poor management support [10, 26]  
SC8.1 Budgetary control requirements and fear of overspending 
SC8.2 Management not involved in the governance of project 
PC9 
Weak stakeholder ‘motivation’ 
for involvement 
[23] 
SC9.1 Low competition in the industry  
SC9.2 Very few plans for improvement in the organisation 
SC9.3 
Poor understanding of stakeholder’s needs and 
expectations  
PC10 
Scepticism towards classic 
management approaches 
 [22, 31, 
26] 
SC10.1 
Cases of failure in delivering real benefits to the healthcare 
services in the past 
SC10.2 Morally unacceptable 







Difficulties with understanding  
and working with simulation 
tools, techniques and models 
[18, 10] 
SC11.1 Poor interactivity  
SC11.2 User-unfriendliness of tools or techniques  
SC11.3 Poor conceptual modelling 
PC12 
Unacceptable results for 
stakeholders 
[10] 
SC12.1 Poor presentation of results 
SC12.2 Incorrect or biased models  
SC12.3 Incomplete models  










t PC13 Lengthy project [32] 
SC13.1 Lengthy activities  
SC13.2 Poor time management 
PC14 




SC14.1 Too much work for a simple solution 
PC15 
Failure to meet project 
objectives 
[10] 
SC15.1 Ill-defined objectives 
SC15.2 Lack of focus on objectives 
PC16 
Poor team efforts from either 
side 
[29] 
SC16.1 Weak teamwork from simulation modellers side 
SC16.2 Weak teamwork from stakeholders side 

















Healthcare problems are very 
complex to model 
[30, 31, 
32, 27]  
SC17.1 Much variations involved  
SC17.2 
Different views from a large number of different 
stakeholders involved  
SC17.3 Dynamic and multi-dimensional nature of healthcare  
  
PC18 Confidentiality issues [22] SC18.1 Confidentiality of patient data and/or ethical issues  




Table 2. Survey data and descriptive statistics about primary and secondary factors, based on both the original and bootstrapped data 


















Original sample (n=37) Bootstrapped sample (n= 1000) Decision 
Mean Med Mod SD Mean Med Mod SD 
Retained (R) 
Excluded (E) 
PC1 2 14 7 13 1 0 0 2.92 3 2 1.04 3.26 4 4 0.99 E 
SC1.1 0 19 2 15 1 0 0 2.95 2 2 1.03 2.99 3 2 1.01 E 
SC1.2 1 12 9 9 2 0 4 2.97 3 2 1.02 3.12 3 4 1.02 E 
PC2 14 14 6 3 0 0 0 1.95 2 1a 0.94 1.91 2 1 0.93 R 
SC2.1 1 11 7 15 0 3 0 2.81 3 4 1.24 2.74 3 4 1.29 E 
SC2.2 8 4 10 7 0 3 5 2.31 3 3 1.33 2.3 3 3 1.35 E 
PC3 17 10 2 5 2 0 1 2.03 2 1 1.28 2.03 2 1 1.25 R 
SC3.1 13 17 4 2 0 0 1  1.86 2 2 0.83 1.89 2 2 0.83 R 
SC3.2 12 13 4 2 1 0 5 1.97 2 2 1.03 2.01 2 2 1.01 R 
PC4 3 19 9 5 1 0 0 2.51 2 2 0.93 2.53 2 2 0.89 R 
SC4.1 4 16 9 4 2 1  1 2.47 2 2 1.11 2.44 2 2 1.06 R 
SC4.2 9 16 5 2 1 1 3 2.03 2 2 1.03 2.03 2 2 1.06 R 
PC5 13 22 2 0 0 0 0 1.7 2 2 0.57 1.73 2 2 0.56 R 
SC5.1 13 16 4 4 0 0 0 1.97 2 2 0.96 2.01 2 2 0.90 R 
SC5.2 5 18 9 4 0 0 1 2.33 2 2 0.86 2.3 2 2 0.80 R 
SC5.3 8 24 2 2 0 1 0 1.89 2 2 0.77 1.89 2 2 0.69 R 
SC5.4 5 17 8 5 0 0 2 2.37 2 2 0.91 2.39 2 2 0.82 R 
PC6 9 16 6 3 0 1  2 2.03 2 2 0.95 2.03 2 2 1.04 R 
SC6.1 13 11 5 6 0 1  1 2.06 2 1 1.15 2.14 2 1 1.17 R 
SC6.2 6 16 8 3 0 1  3 2.18 2 2 0.94 2.14 2 2 0.93 R 
PC7 3 9 8 10 3 2  2 2.86 3 4 1.33 2.7 3 2 1.40 E 
SC7.1 1 7 14 10 1 1  3 3 3 3 1.02 2.9 3 3 1.04 E 
SC7.2 5 15 10 2 0 2  3 3.09 3 3 1.11 3.01 3 3 1.11 E 
SC7.3 1 1 15 12 0 5  3 2.82 3 3 1.36 2.76 3 3 1.34 E 
PC8 6 14 9 2 0 2 4 2.09 2 2 0.98 2.11 2 2 1.02 R 
SC8.1 3 10 10 6 0 3 5 2.41 2.5 2a 1.19 2.34 2 3 1.20 R 
SC8.2 4 13 7 6 0 2 5 2.34 2 2 1.13 2.26 2 2 1.10 R 
PC9 4 17 7 5 1 1 2 2.4 2 2 1.06 2.48 2 2 1.11 R 
SC9.1 0 12 8 9 0 4  4 2.55 3 2 1.25 2.56 3 2 1.26 E 
  
SC9.2 0 7 7 16 1 2 4 3.15 4 4 1.18 3.24 4 4 1.16 E 
SC9.3 1 17 8 4 0 3 4 2.27 2 2 1.04 2.24 2 2 1.05 R 
PC10 5 16 10 5 0 0 1 2.42 2 2 0.91 2.43 2 2 0.79 R 
SC10.1 6 18 3 4 1 3 2 2.06 2 2 1.16 1.99 2 2 1.10 R 
SC10.2 1 4 7 16 5 1 3 3.5 4 4 1.16 3.56 4 4 1.18 E 
SC10.3 0 8 11 8 2 4 4 2.76 3 3 1.35 2.7 3 3 1.40 E 
PC11 11 15 1 7 0 0  3 2.12 2 2 1.09 2.14 2 2 1.12 R 
SC11.1 3 14 7 7 0 0 6 2.58 2 2 0.96 2.64 2 2 0.94 R 
SC11.2 7 16 4 5 0 0 5 2.22 2 2 0.98 2.22 2 2 0.95 R 
SC11.3 7 11 3 10 0 0 6 2.52 2 2 1.18 2.62 2 4 1.19 R 
PC12 0 12 6 16 0 1  2 3.03 3 4 1.04 3.02 3 4 1.07 E 
SC12.1 3 11 9 7 0 1 6 2.58 3 2 1.06 2.64 3 2 1.01 E 
SC12.2 0 12 13 6 0 1 5 2.72 3 3 0.89 2.73 3 3 0.89 E 
SC12.3 2 13 11 4 1 1 5 2.56 2.5 2 1.01 2.59 3 2a 1.09 E 
SC12.4 3 13 12 3 0 1 5 2.41 2 2 0.91 2.41 2 2 0.95 R 
PC13 6 18 6 5 0 0 2 2.29 2 2 0.93 2.3 2 2 0.93 R 
SC13.1 4 16 7 5 0 0 5 2.41 2 2 0.91 2.46 2 2 0.94 R 
SC13.2 3 12 12 3 0 1 6 2.42 2 2a 0.92 2.47 3 3 0.99 E 
PC14 2 16 10 6 0 1 2 2.66 2 2 0.94 2.64 2 2 0.90 R 
SC14.1 1 14 11 2 1 1 7 2.5 2 2 0.94 2.47 2 2 0.83 R 
PC15 0 14 12 7 0 1 3 2.71 3 2 0.91 2.66 3 2 0.93 E 
SC15.1 8 11 9 1 0 1 7 2.03 2 2 0.93 2.02 2 2 0.92 R 
SC15.2 4 17 6 1 1 1 7 2.17 2 2 0.95 2.16 2 2 0.96 R 
PC16 1 10 15 7 0 1 3 2.76 3 3 0.92 2.83 3 3 0.89 E 
SC16.1 0 5 14 9 0 1 8 3.03 3 3 0.91 3.09 3 3 0.87 E 
SC16.2 1 7 16 4 0 1 8 2.72 3 3 0.88 2.79 3 3 0.84 E 
SC16.3 4 12 7 5 0 1 8 2.38 2 2 1.05 2.47 2 2 1.07 R 
PC17 10 18 1 4 0 1 3 2.06 2 2 1.04 2 2 2 1.01 R 
SC17.1 11 16 1 2 1 0 6 1.9 2 2 0.98 1.84 2 2 0.94 R 
SC17.2 12 9 8 2 0 0 6 2 2 1 0.97 2.02 2 1 0.90 R 
SC17.3 9 15 0 3 2 1 7 2.03 2 2 1.22 1.94 2 2 1.15 R 
PC18 3 8 6 12 4 1 3 3.09 3 4 1.31 3.04 3 4 1.28 E 
S.C18.1 4 8 6 9 3 1 6 2.87 3 4 1.34 2.89 3 2 1.32 E 
a. Multiple modes exist. The smallest value is shown. 
Rank codes: 1 = strongly agree, 2 = agree, 3 = neutral, 4 = disagree, 5 = strongly disagree 
  
Table 3. Nonparametric correlations (Kendall's Tau-b) between PCs 
Primary factors Correlation coefficient Significance level (p) 
PC3 ↔ PC11 0.395 0.01 
PC5 ↔ PC11 0.356 0.026 
PC6 ↔ PC9 0.321 0.031 
PC8 ↔ PC9 0.312 0.037 
PC14 ↔ PC17 0.352 0.021 
 
Table 4. Nonparametric correlations (Kendall's Tau-b) between retained SCs 
Secondary factors Correlation coefficient  Significance level (p) 
SC3.1 ↔ SC3.2 0.746 0.001 
SC4.1 ↔ SC4.2 0.406 0.006 
SC5.1 ↔ SC5.2 0.483 0.001 
SC11.1 ↔ SC11.2 0.571 0.000 
SC11.1 ↔ SC11.3 0.385 0.015 
SC15.1 ↔ SC15.2 0.661 0.001 
SC17.1 ↔ SC17.2 0.530 0.001 
SC17.1 ↔ SC17.3 0.543 0.001 













Primary Causal Factors 
2 3 4 5 6 8 9 10 11 12 13 14 15 16 17 
3.1  .637**       .501**   .309*    
3.2  .696** -.334* .331*     .400*       
4.1   .663**   .320*          
4.2   .368*             
5.1    .586**     .420**   .378*    
5.2    .384*     .383*   .328*    
5.3†     .344*           
5.4†,‡                
6.1     .476**  .505**  .431**       
6.2     .497**           
8.1†   .304*        -.446**     
8.2      .493**          
9.3†,‡                
10.1        .417**    .445**   .384* 
11.1         .577**       
11.2         .686**       
11.3†,‡                
12.4†,‡                
13.1           .796**     
14.1     .353*       .419*    
15.1†  .334*     .337*         
15.2†  .323*    .325*          
16.3† .391*               
17.1            .435**   .662** 






        .356*   .355*   .692** 
Notes: Empty cells represent non-significant correlations. †SCs not associated with hypothesised PCs; ‡SCs not associated to any PCs; *Correlation is significant at the 0.05 
level (2-tailed); **Correlation is significant at the 0.01 level (2-tailed) 
  





Reliability analysis  
Original sample 
Bootstrapped sample 









0.640 0.039 0.521 52.534 0.001 0.425 0.417 0.403 
3.2 3 0.628 0.022 0.428 181.771 0.001 0.719 0.715 0.759 
4.1 4 
.836 
0.779 0.019 0.456 107.842 0.001 0.617 0.611 0.666 
4.2 4 0.919 0.034 0.762 5.356 0.024 0.074 0.060 0.098 
5.1 5 
.770 
0.757 0.027 0.507 60.580 0.001 0.460 0.453 0.537 
5.2 5 0.778 0.033 0.563 34.909 0.001 0.330 0.320 0.355 
5.3† 5     ns    
5.4† 5     ns    
6.1 6 
.716 
0.788 0.034 0.574 29.857 0.001 0.308 0.298 0.376 
6.2 6 0.821 0.051 0.695 10.244 0.002 0.133 0.120 0.178 
8.1† 8 
.610 
    ns    
8.2 8 0.815 0.041 0.632 16.846 0.001 0.211 0.198 0.235 
9.3 9 .600 0.711 0.042 0.550 34.041 0.001 0.358 0.348 0.413 
10.1 10 .790 0.830 0.034 0.604 20.806 0.001 0.254 0.242 0.261 
11.1 11 
.875 
0.696 0.034 0.515 56.006 0.001 0.441 0.433 0.389 
11.2 11 0.638 0.021 0.425 193.663 0.001 0.732 0.728 0.755 
11.3† 11     ns    
13.1 13 .899 0.678 0.021 0.436 157.568 0.001 0.689 0.685 0.707 
14.1 14 .601 0.850 0.041 0.687 11.313 0.001 0.141 0.128 0.131 
17.1 17 
.891 
0.737 0.030 0.514 56.740 0.001 0.444 0.436 0.657 
17.2 17 0.716 0.035 0.536 45.315 0.001 0.390 0.381 0.307 
17.3 17 0.767 0.029 0.521 49.394 0.001 0.424 0.416 0.561 
 Alternative PCs          
3.1 11 .628 0.721 0.047 0.599 25.299 0.001 0.263 0.252 0.229 
3.1 14 .301 0.890 0.039 0.738 7.212 0.009 0.092 0.079 0.070 
3.2 5 ---     ns    
3.2 11 .500 0.803 0.044 0.651 16.060 0.001 0.184 0.173 0.130 
4.1 8 .450 0.864 0.043 0.709 8.470 0.005 0.119 0.105 0.153 
5.1 11 .600 0.768 0.047 0.632 18.934 0.001 0.211 0.199 0.172 
5.1 14 .592 0.862 0.032 0.652 15.929 0.001 0.183 0.172 0.182 
5.2 11 .533 0.706 0.042 0.566 34.038 0.001 0.324 0.315 0.265 
5.2 14 ---     ns    
  

















5.3 6 .700 0.671 0.041 0.536 42.740 0.001 0.389 0.380 0.439 
6.1 9 .667 0.741 0.024 0.470 88.965 0.001 0.570 0.564 0.573 
6.1 11 ---     ns    
10.1 14 .601 0.876 0.039 0.703 8.641 0.005 0.124 0.110 0.095 
10.1 17 .595 0.865 0.054 0.752 5.384 0.024 0.081 0.066 0.028 
14.1 6 .522 0.765 0.052 0.644 15.651 0.001 0.194 0.182 0.250 
15.1 3 ---     ns    
15.1 9 ---     ns    
15.2 3 ---     ns    
15.2 8 .523 0.848 0.045 0.695 9.633 0.003 0.133 0.119 0.176 
16.3 2 ---     ns    
17.1 14 .574 0.909 0.034 0.748 6.556 0.013 0.085 0.072 0.059 
17.2 14 .654 0.863 0.036 0.679 12.554 0.001 0.150 0.138 0.120 
17.3 11 .479 0.822 0.044 0.664 13.521 0.001 0.168 0.155 0.157 
17.3 14 ----     ns    
  
Table 7: Top three statistically significant PCs (mean and median ratings ≤ 2)  
# Code Primary causal factor 
1 PC5 
Communication gap between simulation and stakeholder 
groups 
2 PC2 Stakeholder’s (e.g. clinician’s) high workload 
3 PC17 Healthcare problems are very complex to model 
 
 
Table 8: Top five statistically significant SCs (mean and median ratings ≤2) 
# Code Secondary causal factor 
1 SC17.1 Much variations involved 
2 SC5.3 Irregular contacts between simulation and stakeholder groups 
3 SC3.1 Stakeholders’ low exposure to simulation projects 
4 SC17.3 Dynamic and multi-dimensional nature of healthcare 
5 SC10.1 
Cases of failure in delivering real benefits to the healthcare 
services in the past 
   
 
 
 
